Metabolic Disease Clinical Trial
Official title:
The Effects of a Single Day of Mixed Macronutrient Overfeeding on Energy Balance and Metabolic Responses in Healthy Young Men
NCT number | NCT03301948 |
Other study ID # | 34693 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2017 |
Est. completion date | January 11, 2019 |
Verified date | January 2019 |
Source | Leeds Beckett University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Healthy male participants are recruited to observe potentially deleterious changes in appetite regulation and metabolic control. Participants will be provided with an energy intake representative of their daily requirements on the first day of one trial and will be provided with an additional 50% energy intake on the first day of another trial. Outcome variables will be assessed during the second day of each trial in response to a fixed mixed macronutrient meal tolerance test.
Status | Completed |
Enrollment | 12 |
Est. completion date | January 11, 2019 |
Est. primary completion date | January 11, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - weight stable - healthy Exclusion Criteria: - any personal history of cardiovascular or metabolic disease - smokers - currently dieting - taking any medication known to influence appetite or metabolic outcomes - highly active (IPAQ category 3) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Leeds Beckett University | Leeds |
Lead Sponsor | Collaborator |
---|---|
Leeds Beckett University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Appetite perceptions assessed using 100mm visual analogue scales | Appetite perceptions using 100mm visual analogue scales | 28 hours | |
Primary | Ad libitum energy intake | Ad libitum energy intake using an ad libitum pasta meal | 28 hours | |
Primary | Plasma acylated ghrelin concentrations | Measured using ELISA from venous blood samples | 28 hours | |
Primary | Plasma peptide YY concentrations | Measured using ELISA from venous blood samples | 28 hours | |
Primary | Plasma GLP-1 concentrations | Measured using ELISA from venous blood samples | 28 hours | |
Secondary | Palatability perceptions assessed using 100mm visual analogue scales | Palatability of the test meals assessed via 100mm visual analogue scales during the first day of each trial | 28 hours | |
Secondary | Blinding assessment | To assess whether the blinding of dietary manipulation of the first day of each trial was successful. This will be assessed via an exit questionnaire which requires qualitative responses regarding any noticeable differences in the foods provided and what aspect of the food the participants thought had been manipulated during the trials. | One week | |
Secondary | Plasma insulin concentrations | Measured using ELISA from venous blood samples | 28 hours | |
Secondary | Plasma glucose concentrations | Measured using photometric analysis from venous blood samples | 28 hours | |
Secondary | Plasma triglyceride concentrations | Measured using photometric analysis from venous blood samples | 28 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06188728 -
Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05081037 -
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Not yet recruiting |
NCT05461144 -
AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
|
||
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A | |
Active, not recruiting |
NCT05505994 -
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
|
Phase 3 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Recruiting |
NCT05711758 -
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
|
||
Recruiting |
NCT05112029 -
Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
|
||
Recruiting |
NCT03682640 -
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT04854603 -
Dairy Products With Reduced Sugar and Blood Glucose
|
N/A | |
Recruiting |
NCT06024291 -
Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial
|
N/A | |
Recruiting |
NCT04904601 -
Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects
|
N/A | |
Recruiting |
NCT04109586 -
Diet and Fat Mass After Traumatic Spinal Cord Injury
|
N/A | |
Recruiting |
NCT06009653 -
Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
|
Phase 4 | |
Completed |
NCT03067012 -
Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients
|
N/A | |
Recruiting |
NCT03309423 -
Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
|
N/A |